Bromo-DragonFLY is known to produce thought connectivity, a cognitive effect. A state in which disparate thoughts, concepts, and ideas become fluidly and spontaneously interconnected, revealing patterns and relationships that are normally overlooked. The mind weaves together seemingly unrelated subjects into a unified web of associations, often producing novel insights or a profound sense of conceptual coherence.
Thought connectivity describes a cognitive state in which the mind draws unusually rich connections between ideas, memories, sensory experiences, and abstract concepts. From a first-person perspective, it feels as though the barriers between mental compartments have dissolved — a song lyric might suddenly illuminate a childhood memory, which in turn connects to a philosophical principle, which then links to a scientific concept. The experience is often accompanied by a sense of revelation, as though one is perceiving the hidden architecture of knowledge itself.
At low intensities, thought connectivity manifests as enhanced associative thinking — noticing more metaphors, seeing more angles on a problem, or finding unexpected links between topics in conversation. At moderate levels, the connections become more prolific and often more abstract, spanning disparate domains of knowledge and experience. At high intensities, thought connectivity can become so pervasive that everything seems meaningfully related to everything else, sometimes producing genuine epiphanies but also sometimes generating connections that are tenuous or illusory. At the extreme, it can shade into apophenia — the perception of meaningful patterns where none exist.
There are several recognizable subtypes. Conceptual connectivity involves links between abstract ideas and frameworks. Autobiographical connectivity weaves together personal memories and life events into perceived patterns. Sensory-conceptual connectivity links perceptual experiences to ideas, as when a texture evokes a mathematical concept or a color suggests an emotion. Universal connectivity is the most intense form, in which all phenomena — internal and external — appear as facets of a single interconnected whole.
The neuroscience of thought connectivity implicates increased communication between brain regions that normally operate independently. Neuroimaging studies of psychedelics show increased functional connectivity across the brain, particularly between the default mode network (involved in self-referential thought) and other networks. Serotonergic agonism at 5-HT2A receptors appears central, as it reduces the filtering and gating functions that normally constrain associative processes. Reduced activity in the claustrum and thalamic gating circuits may also play a role.
This effect is most characteristically produced by serotonergic psychedelics such as LSD, psilocybin, DMT, and mescaline. It is also commonly reported with cannabis, particularly at higher doses or with sativa-dominant strains. Dissociatives like ketamine can produce a distinctive form of thought connectivity, often with a more abstract or philosophical character. MDMA and other empathogens tend to produce connectivity that is more emotionally and interpersonally oriented.
While thought connectivity is generally experienced as positive and can facilitate creative work and self-understanding, it carries risks at high intensities. The inability to distinguish genuine insights from spurious connections can lead to delusional thinking, particularly in individuals predisposed to psychosis. The sheer volume of connections can also become cognitively exhausting or anxiety-inducing. Integration practices — writing down insights for later sober evaluation — are strongly recommended. Thought connectivity often synergizes with conceptual thinking and introspection, and can become destabilizing when combined with thought acceleration.
Thought connectivity can manifest at varying intensities depending on the dose of Bromo-DragonFLY and individual sensitivity. The following levels describe the typical progression of this effect.
Slightly enhanced associative thinking. One notices a few more connections between ideas than usual, such as catching a metaphor or seeing an analogy more easily.
Clearly increased linking between concepts. Conversations become more tangential in a productive way. Creative problem-solving feels enhanced.
Rich, spontaneous interconnection of disparate ideas spanning multiple domains. Insights feel genuinely novel. One may feel compelled to write or discuss discoveries.
Everything seems deeply interconnected. Patterns and relationships emerge constantly, spanning personal history, philosophy, science, and sensory experience. Can feel overwhelming.
Total conceptual interconnection where all phenomena appear as expressions of a unified whole. May shade into apophenia. Difficult to isolate individual thoughts from the web of associations.
The hallucinogenic effect of bromo-DragonFLY is mediated by its agonist activity at the 5-HT2A serotonin receptor. Bromo-DragonFLY also has a high binding affinity for the 5-HT2B and 5-HT2C serotonin receptors, and is most accurately described as a non-subtype selective 5-HT2 agonist, as it is actually twice as potent an agonist for 5-HT2C receptors as for 5-HT2A, as well as being less than 5x selective for 5-HT2A over 5-HT2B.
It is further suggested that Bromo-DragonFLY almost completely inhibits MAO-A activity, which makes itself unable to metabolize. This is probably the cause for an abnormal duration of action.
However, the role of these interactions and how they result in the psychedelic experience continues to remain elusive.
Compared to LSD, this compound presents a significantly less pronounced body high, reduced visual effects and more in-depth hallucinations which are comparable to mescaline or 2C-B. Despite the visual and physical effects, it reportedly tends to maintain a level of sober thought structure. As the user usually retains acute cognitive sobriety, Bromo-DragonFLY can be considered to have diminished effects of confusion and potential delusions when compared to 4-AcO-DMT, psilocin, or LSD.
Bromo-DragonFLY can be considered extremely toxic at very high dosages with several deaths and numerous hospitalizations reported on overdoses. It can also have vasoconstrictive effects]], which can result in severe tissue damage or even limb amputation. Due to its high potency,one can easily overdose if this substance is not measured correctly ("eyeballed") or mislabeled as another substance.
The toxicity and long-term health effects of recreational Bromo-toxic dose is unknown. This is because Bromo-DragonFLY is a research chemical with very little history of human usage.
It is strongly recommended that one use harm reduction practices, such as volumetric dosing, when using this substance to ensure the accurate administration of the intended dose.
On May 7, 2011, in the United States, two young adults died and several others were hospitalized after overdosing on Bromo-DragonFLY, which they believed was 2C-E.
Bromo-not habit-forming, and the desire to use it can actually decrease with use. It is most often self-regulating.
Tolerance to the effects of Bromo-almost immediately after ingestion. After that,614 days to be back at baseline (in the absence of further consumption). Bromo-DragonFLY presents cross-tolerance with Cross-all psychedelics, meaning that after the consumption of Bromo-DragonFLY all psychedelics will have a reduced effect.
The risk of Bromo-DragonFLY overdose is unknown at the time, suggesting that there may not be a safe dosage. Non-oral routes also seem to exhibit a higher chance of overdosing, perhaps owing to differences in bioavailability, potency and unpredictability of dosage and effects. Overdose effects of typically include bizarre, delusional and sometimes violent behavior, amnesia, numbness, confusion and anxiety. The user may not be able to communicate and can be severely agitated. At appropriately high doses, more severe side effects include panic attacks, seizures, dangerously prolonged elevated heart rate, blood pressure and vasoconstriction. Vasoconstriction typically develops to its peak several hours into the intoxication and will need medical assistance since Bromo-DragonFLY is known to do this for an extremely long time.
The abnormally long duration of Bromo-DragonFLY poses a significant risk by staying inside the body for weeks.
In the event of an overdose, benzodiazepines can be administered to mitigate the hyper-agitative effects. A potent vasodilator will need to be continuously administered to prevent a hypertensive emergency, necrosis, organ failure and death from the resulting hypoxia. As a result, emergency medical services should always be sought in the event of an overdose.
Australia:** Bromo-DragonFLY is nationally a Schedule 9 substance, making it illegal to possess, produce and sell.
Canada:** Bromo-DragonFLY was listed as a Schedule III Substance as of October 12, 2016, along several other research chemicals.
Denmark:** Possession, production and sale is illegal.
Finland:** Possession, production and sale is illegal.
Germany:** Bromo-DragonFLY is controlled under the NpSG, as it is a derivative of 2-Phenethylamine. Production and sale is illegal. Possession and import, although illegal, is not penalized if intended for self-consumption.
Japan: Bromo-DragonFLY is a controlled substance in Japan effective August 19th, 2015.
Norway:** Bromo-DragonFLY is considered a narcotic in Norway.
Romania:** Possession, production and sale is illegal.
Sweden:** Bromo-DragonFLY is listed as a Schedule IV substance, making it illegal to possess, produce and sell.
Switzerland: Bromo-DragonFLY is likely illegal in Switzerland. It is unclear whether Bromo-DragonFLY is in the scope of a substituted a-methylphenethylamine under Verzeichnis E point 130, since it is not an "alkyl, alkoxy, alkylenedioxy or halide derivative of phenethylamine", while additionally containing further univalent substituents, according to the scope. It is also unclear if it can be considered a true ether analog of an ether analog of DOB, which would make it controlled under Buchstabe C. It could be considered an ether analog of an ether analog of para-bromoamphetamine, which would also make it illegal under Buchstabe C, but the extent of all these definitions are unknown.
Turkey:** Bromo-DragonFLY is a classed as drug and is illegal to possess, produce, supply, or import.
United Kingdom** - It is illegal to produce, supply, or import this substance under the Psychoactive Substance Act, which came into effect on May 26th, 2016.
United States:** Bromo-DragonFLY is listed as a Schedule I substance in Oklahoma.The Oklahoman, "https://www.oklahoman.com/story/news/crime/2012/08/13/man-sentenced-in-2011-designer-drug-deaths-of-two-oklahoma-college-students/61052749007/ Man sentenced in 2011 designer drug deaths of two Oklahoma college students"
Responsible use
Volumetric dosing
Research chemicals
Substituted phenethylamines
Bromo-DragonFLY (Wikipedia)
Bromo-DragonFLY (Erowid Vault)
Bromo-DragonFLY (Isomer Design)
Bromo-DragonFLY (Drugs-Forum)
Bromo-DragonFLY can be administered via oral. The route of administration can influence both the onset and intensity of thought connectivity.
The intensity of thought connectivity depends heavily on the dose of Bromo-DragonFLY. Effects like thought connectivity are typically reported at common to strong doses. Below is the full dosage chart for Bromo-DragonFLY.
Warning
At extreme intensities, thought connectivity can produce apophenia — seeing meaningful connections where none actually exist. This can contribute to paranoid or delusional thinking, particularly in individuals with a predisposition to psychotic disorders. Insights generated during this state should be critically evaluated during sobriety.
Yes. Thought connectivity is a documented cognitive effect of Bromo-DragonFLY. A state in which disparate thoughts, concepts, and ideas become fluidly and spontaneously interconnected, revealing patterns and relationships that are normally overlooked. The mind weaves together seemingly unrelated subjects into a unified web of associations, often producing novel insights or a profound sense of conceptual coherence.
Effects like thought connectivity are typically reported at common doses and above. A common oral dose of Bromo-DragonFLY is 300–500 µg.
Other substances documented to produce thought connectivity include LSD, Mescaline, Cannabis, MDMA, Psilocybin Mushrooms, and 35 more.